Low-to-Moderate Dosage and Short-Term Use of Corticosteroids Benefit Patients With Severe COVID-19 Infections

Low-to-Moderate Dosage and Short-Term Use of Corticosteroids Benefit Patients With Severe COVID-19 Infections

Although the FDA has given emergency use authorization (EUA) for some antiviral drugs for the treatment of COVID-19, no direct antiviral drugs have been identified for the treatment of critically ill patients, the most important treatment is suppression of the hyperinflammation. The purpose of this...

Full description

Bibliographic Details
Main Authors: Liuqing Yang, Ling Peng, Weibo Wu, Mengli Cao, Chuming Chen, Fuxiang Wang, Jennifer St. Sauver, Yingxia Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Microbiology
Subjects:
Coronavirus Disease 2019 (COVID-19)
corticosteroid
propensity score matching (PSM)
mortality rate
severe and critical illness
Online Access:https://www.frontiersin.org/articles/10.3389/fmicb.2022.953328/full

Internet

https://www.frontiersin.org/articles/10.3389/fmicb.2022.953328/full

Similar Items